Fig. 2From: The prevalence of lynch syndrome (DNA mismatch repair protein deficiency) in patients with primary localized prostate cancer using immunohistochemistry screeningInitial serum PSA 5.82 ng/mL, adenocarcinoma, GS 4 + 3 with tertiary 5, pT3aN0, EPE1, RM1, ly0, v1, pn1. H&E × 40Back to article page